VOTRIENT (pazopanib hydrochloride) – Important Change to Frequency of Liver Test Monitoring – For the Public

This is duplicated text of a letter from GlaxoSmithKline Inc. Contact the company for a copy of any references, attachments or enclosures.
Healthy Canadians -Recalls and Safety Alerts – MedEffect Canada – For the Public

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us